Global Preventable Vaccines Market 2015-2019

予防ワクチンの世界市場:弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチン

◆タイトル:Global Preventable Vaccines Market 2015-2019
◆商品コード:IRTNTR5256
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年2月18日
◆ページ数:137
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Five UserUSD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、予防ワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、予防ワクチンの世界市場規模及び予測、種類別分析、製品別分析、市場シェア、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Preventable Vaccines
Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age.

TechNavio’s analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Preventable Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of preventable vaccines. The report examines the market for vaccines used in humans. It covers only commercialized vaccines for diseases that are vaccine preventable.

The report does not cover emerging vaccines for diseases that are not currently vaccine preventable, such as Ebola infection, Epstein-Ban virus infection, Alzheimer’s disease, diabetes, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, or West Nile virus infection.

The report has broadly categorized preventable vaccines into two major segments:
• Adult Preventable Vaccines
• Pediatric Preventable Vaccines

TechNavio’s report, the Global Preventable Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Preventable Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Sanofi

[Other Prominent Vendors]
• Abbott
• AstraZeneca
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Bharat Immunologicals and Biologicals
• bioCSL
• Bio Med
• Crucell
• Dynavax Technologies
• Indian Immunologicals
• Janssen Pharmaceuticals
• Kaketsuken
• LG Life Sciences
• Mitsubishi Tanabe Pharma
• Lupin
• Nuron
• Protein Sciences
• Panacea Biotec
• Roche
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Serum Institute of India
• Sinovac Biotech
• S K Chemicals
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• Zydus Cadila

[Market Driver]
• Inclusion in NIP
• For a full, detailed list, view our report

[Market Challenge]
• Inadequate Vaccine Coverage
• For a full, detailed list, view our report

[Market Trend]
• Increase in Strategic Alliances
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Vaccine Approval Process

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019
07.4 Five Forces Analysis

08.Market Segmentation by Type of Vaccine
08.1 Live Attenuated Vaccine
08.2 Killed Vaccine
08.3 Toxoid Vaccine
08.4 Genetically Modified/Engineered Vaccine

09.Market Segmentation by Product Type
09.1 Polysaccharide Vaccines
09.2 Conjugate Vaccines

10.Geographical Segmentation

11.Global Preventable Vaccines Market by Key Geographies
11.1 Market Size and Forecast for the US
11.2 Market Size and Forecast for the EU
11.3 Market Size and Forecast for Japan
11.4 Market Size and Forecast for India
11.5 Market Size and Forecast for China

12.Global Pediatric Preventable Vaccines Market
12.1 Global Pediatric Preventable Vaccine Market
12.1.1 Market Size and Forecast
12.2 Market Segmentation of the Global Pediatric Preventable Vaccine Market
12.3 Global Pediatric Hepatitis Vaccines Market
12.3.1 Market Size and Forecast
12.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccines Market
12.4.1 Market Size and Forecast
12.5 Global Pediatric MMR Vaccines Market
Market Size and Forecast
12.6 Global Pediatric Combination Vaccines Market
12.6.1 Market Size and Forecast
12.7 Global Pediatric Pneumococcal Vaccines Market
12.7.1 Market Size and Forecast
12.8 Global Polio Vaccines Market
12.8.1 Market Size and Forecast
12.9 Global Pediatric Varicella Vaccines Market
12.9.1 Market Size and Forecast
12.10 Global Other Pediatric Vaccines Market
12.10.1 Market Size and Forecast
12.11 Global Pediatric Preventable Vaccines Market 2014 and 2019 (by percentage)

13.Global Adult Preventable Vaccines Market
13.1 Market Size and Forecast
13.2 Market Segmentation of the Global Adult Preventable Vaccines Market
13.3 Global Adult Cervical Vaccines Market
13.3.1 Market Size and Forecast
13.4 Global Adult Hepatitis Vaccines Market
13.4.1 Market Size and Forecast
13.5 Global Adult Influenza Vaccines Market
13.5.1 Market Size and Forecast
13.6 Global Adult Pneumococcal Vaccines Market
13.6.1 Market Size and Forecast
13.7 Global Adult Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market
13.7.1 Market Size and Forecast

14.Key Leading Countries
14.1 US
14.2 China
14.3 Japan
14.4 India

15.Buying Criteria

16.Market Growth Drivers

17.Drivers and their Impact

18.Market Challenges

19.Impact of Drivers and Challenges

20.Market Trends

21.Trends and their Impact

22.Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2014
22.2.1 GlaxoSmithKline
22.2.2 Merck
22.2.3 Novartis
22.2.4 Pfizer
22.2.5 Sanofi
22.3 Other Prominent Vendors

23.Key Vendor Analysis
23.1 GlaxoSmithKline
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation
23.1.4 Business Segmentation by Revenue 2012 and 2013
23.1.5 Sales by Geography
23.1.6 Pipeline Products
23.1.7 Business Strategy
23.1.8 Key Information
23.1.9 SWOT Analysis
23.2 Merck
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Business Segmentation by Revenue 2012 and 2013
23.2.5 Sales by Geography
23.2.6 Business Strategy
23.2.7 Key Developments
23.2.8 SWOT Analysis
23.3 Novartis
23.3.1 Key Facts
23.3.2 Business Description
23.3.3 Business Segmentation
23.3.4 Revenue by Business Segmentation
23.3.5 Revenue Comparison 2012 and 2013
23.3.6 Sales by Geography
23.3.7 Business Strategy
23.3.8 Key Developments
23.3.9 SWOT Analysis
23.4 Pfizer
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue
23.4.6 Business Strategy
23.4.7 Key Developments
23.4.8 SWOT Analysis
23.5 Sanofi
23.5.1 Key Facts
23.5.2 Business Description
23.5.3 Business Segmentation
23.5.4 Revenue by Business Segmentation
23.5.5 Revenue Comparison 2012 and 2013
23.5.6 Sales by Geography
23.5.7 Business Strategy
23.5.8 Key Developments
23.5.9 SWOT Analysis

24.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Vaccine Approval Process
Exhibit 3: Global Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 4: Global Preventable Vaccines Market Categories
Exhibit 5: Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019 (US$ million)
Exhibit 6: Global Preventable Vaccines Market Share by Vaccine Type 2014 and 2019
Exhibit 7: Global Preventable Vaccines Market Segmentation by Type of Vaccine
Exhibit 8: Global Preventable Vaccines Market Segmentation by Product Type
Exhibit 9: Global Preventable Vaccines Market by Geographical Segmentation 2014
Exhibit 10: Global Preventable Vaccines Market by Region 2014-2019 (US$ million)
Exhibit 11: Global Preventable Vaccines Market in the US 2014-2019 (US$ million)
Exhibit 12: Global Preventable Vaccines Market in the EU 2014-2019 (US$ million)
Exhibit 13: Global Preventable Vaccines Market in Japan 2014-2019 (US$ million)
Exhibit 14: Global Preventable Vaccines Market in India 2014-2019 (US$ million)
Exhibit 15: Global Preventable Vaccines Market in China 2014-2019 (US$ million)
Exhibit 16: Global Pediatric Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 17: Global Pediatric Preventable Vaccines Market Segmentation
Exhibit 18: Global Pediatric Hepatitis Vaccines Market 2014-2019 (US$ million)
Exhibit 19: Global Pediatric Haemophilus Influenzae Type B Vaccines Market 2014-2019 (US$ million)
Exhibit 20: Global Pediatric MMR Vaccine Market 2014-2019 (US$ million)
Exhibit 21: Global Pediatric Combination Vaccines Market 2014-2019 (US$ million)
Exhibit 22: Global Pediatric Pneumococcal Vaccines Market 2014-2019 (US$ million)
Exhibit 23: Global Polio Vaccines Market 2014-2019 (US$ million)
Exhibit 24: Global Pediatric Varicella Vaccines Market 2014-2019 (US$ million)
Exhibit 25: Global Other Pediatric Vaccines Market 2014-2019 (US$ million)
Exhibit 26: Global Pediatric Preventable Vaccines Market by Vaccine Segmentation (2014 and 2019) (US$ Million)
Exhibit 27: Global Pediatric Preventable Vaccines Market by Vaccine Segmentation 2014 (in %)
Exhibit 28: Global Pediatric Preventable Vaccines Market by Vaccine Segmentation 2019 (in %)
Exhibit 29: Snapshot of Global Pediatric Preventable Vaccines Market by Segments 2014-2019
Exhibit 30: Global Adult Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 31: Global Adult Cervical Vaccines Market 2014-2019 (US$ million)
Exhibit 32: Global Adult Hepatitis Vaccines Market 2014-2019 (US$ million)
Exhibit 33: Global Adult Influenza Vaccine Market 2014-2019 (US$ million)
Exhibit 34: Global Adult Pneumococcal Vaccines Market 2014-2019 (US$ million)
Exhibit 35: Global Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market 2014-2019 (US$ million)
Exhibit 36: Global Adult Preventable Vaccines Market by Vaccine Segmentation (2014 and 2019) (US$ Million)
Exhibit 37: Global Adult Preventable Vaccines Market by Vaccine Segmentation 2014 (in %)
Exhibit 38: Global Adult Preventable Vaccines Market by Vaccine Segmentation 2019 (in %)
Exhibit 39: Snapshot of Global Adult Preventable Vaccines Market by Segments 2014-2019
Exhibit 40: Buying Criteria of the Global Preventable Vaccines Market
Exhibit 41: Drivers and their Impact on the Key Customer Category of the Global Preventable Vaccines Market
Exhibit 42: Drivers and their Impact on Geographies in Global Preventable Vaccines Market
Exhibit 43: GlaxoSmithKline’s Revenue 2013
Exhibit 44: GlaxoSmithKline: Vaccine Pipeline
Exhibit 45: Merck’s Revenue 2013
Exhibit 46: Novartis’ Revenue 2013
Exhibit 47: Novartis: Vaccine Pipeline
Exhibit 48: Pfizer’s Revenue 2013
Exhibit 49: Sanofi’s Revenue 2013
Exhibit 50: GlaxoSmithKline: Business Segmentation 2013
Exhibit 51: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 52: GlaxoSmithKline: Sales by Geography 2013
Exhibit 53: GlaxoSmithKline: Pipeline Products 2013
Exhibit 54: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 55: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 56: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 57: Novartis AG: Business Segmentation
Exhibit 58: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 59: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 60: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 61: Pfizer: Business Segmentation by Revenue 2013
Exhibit 62: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 63: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 64: Sanofi SA: Business Segmentation
Exhibit 65: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 66: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 67: Sanofi SA: Sales Revenue by Geographical Segmentation 2013



【掲載企業】

GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi , Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals , bioCSL, Bio Med , Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals,Kaketsuken, LG Life Sciences, Mitsubishi Tanabe Pharma, Lupin, Nuron , Protein Sciences, Panacea Biotec, Roche, Serum Institute of India , Shenzhen Kangtai Biological Products , Serum Institute of India, Sinovac Biotech, S K Chemicals,Takeda Pharmaceutical , Valeant Pharmaceuticals, Zydus Cadila

【資料のキーワード】

予防ワクチン、弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチン、多糖体ワクチン、結合型ワクチン、製薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[予防ワクチンの世界市場:弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチン] (Global Preventable Vaccines Market 2015-2019 / IRTNTR5256)販売に関する免責事項
[予防ワクチンの世界市場:弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチン] (Global Preventable Vaccines Market 2015-2019 / IRTNTR5256)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆